These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 14755628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN, Der TC, Renish L, Osredkar T, Hagner D, Reploge M, Sakakibara S, Ueda S.
    Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL, Pierrotti D, Joyce JN.
    Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
    [Abstract] [Full Text] [Related]

  • 6. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.
    Neurobiol Dis; 2011 Jun 01; 42(3):391-403. PubMed ID: 21303698
    [Abstract] [Full Text] [Related]

  • 8. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y, Gandia C, Huang PL, Ali SF.
    J Pharmacol Exp Ther; 1998 Mar 01; 284(3):1040-7. PubMed ID: 9495865
    [Abstract] [Full Text] [Related]

  • 9. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
    Hayashi T, Hirata H, Asanuma M, Ladenheim B, Tsao LI, Cadet JL, Su TP.
    Synapse; 2001 Mar 15; 39(4):305-12. PubMed ID: 11169780
    [Abstract] [Full Text] [Related]

  • 10. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice.
    Dluzen DE.
    Neurosci Lett; 2004 Apr 15; 359(3):135-8. PubMed ID: 15050682
    [Abstract] [Full Text] [Related]

  • 11. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
    D'Astous M, Gajjar TM, Dluzen DE, Di Paolo T.
    Neuroendocrinology; 2004 Apr 15; 79(6):296-304. PubMed ID: 15249736
    [Abstract] [Full Text] [Related]

  • 12. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RR.
    J Neurochem; 2004 Oct 15; 91(2):362-73. PubMed ID: 15447669
    [Abstract] [Full Text] [Related]

  • 13. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE.
    J Pharmacol Exp Ther; 2000 Dec 15; 295(3):1077-85. PubMed ID: 11082443
    [Abstract] [Full Text] [Related]

  • 14. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z, Cawthon D, McCastlain KA, Slikker W, Ali SF.
    Synapse; 2005 Jan 15; 55(1):45-51. PubMed ID: 15499605
    [Abstract] [Full Text] [Related]

  • 15. Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization.
    Chen PC, Lao CL, Chen JC.
    J Neurochem; 2007 Jan 15; 100(1):225-41. PubMed ID: 17101033
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice.
    Dluzen DE, Gao X, Story GM, Anderson LI, Kucera J, Walro JM.
    Exp Neurol; 2001 Jul 15; 170(1):121-8. PubMed ID: 11421589
    [Abstract] [Full Text] [Related]

  • 17. Free radical production induced by methamphetamine in rat striatal synaptosomes.
    Pubill D, Chipana C, Camins A, Pallàs M, Camarasa J, Escubedo E.
    Toxicol Appl Pharmacol; 2005 Apr 01; 204(1):57-68. PubMed ID: 15781294
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC, Dluzen DE.
    Brain Res; 2004 Dec 17; 1029(2):186-94. PubMed ID: 15542073
    [Abstract] [Full Text] [Related]

  • 20. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure.
    Bowyer JF, Robinson B, Ali S, Schmued LC.
    Synapse; 2008 Mar 17; 62(3):193-204. PubMed ID: 18081184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.